PortalPublikationenManaging hematological cancer patients during the COVID-19 p...

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

Standard

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus. / Buske, C; Dreyling, M; Alvarez-Larrán, A; Apperley, J; Arcaini, L; Besson, C; Bullinger, L; Corradini, P; Giovanni Della Porta, M; Dimopoulos, M; D'Sa, S; Eich, H T; Foà, R; Ghia, P; da Silva, M G; Gribben, J; Hajek, R; Harrison, C; Heuser, M; Kiesewetter, B; Kiladjian, J J; Kröger, N; Moreau, P; Passweg, J R; Peyvandi, F; Rea, D; Ribera, J-M; Robak, T; San-Miguel, J F; Santini, V; Sanz, G; Sonneveld, P; von Lilienfeld-Toal, M; Wendtner, C; Pentheroudakis, G; Passamonti, F.

in: ESMO OPEN, Jahrgang 7, Nr. 2, 100403, 04.2022.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Buske, C, Dreyling, M, Alvarez-Larrán, A, Apperley, J, Arcaini, L, Besson, C, Bullinger, L, Corradini, P, Giovanni Della Porta, M, Dimopoulos, M, D'Sa, S, Eich, HT, Foà, R, Ghia, P, da Silva, MG, Gribben, J, Hajek, R, Harrison, C, Heuser, M, Kiesewetter, B, Kiladjian, JJ, Kröger, N, Moreau, P, Passweg, JR, Peyvandi, F, Rea, D, Ribera, J-M, Robak, T, San-Miguel, JF, Santini, V, Sanz, G, Sonneveld, P, von Lilienfeld-Toal, M, Wendtner, C, Pentheroudakis, G & Passamonti, F 2022, 'Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus', ESMO OPEN, Jg. 7, Nr. 2, 100403. https://doi.org/10.1016/j.esmoop.2022.100403

APA

Buske, C., Dreyling, M., Alvarez-Larrán, A., Apperley, J., Arcaini, L., Besson, C., Bullinger, L., Corradini, P., Giovanni Della Porta, M., Dimopoulos, M., D'Sa, S., Eich, H. T., Foà, R., Ghia, P., da Silva, M. G., Gribben, J., Hajek, R., Harrison, C., Heuser, M., ... Passamonti, F. (2022). Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus. ESMO OPEN, 7(2), [100403]. https://doi.org/10.1016/j.esmoop.2022.100403

Vancouver

Buske C, Dreyling M, Alvarez-Larrán A, Apperley J, Arcaini L, Besson C et al. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus. ESMO OPEN. 2022 Apr;7(2). 100403. https://doi.org/10.1016/j.esmoop.2022.100403

Bibtex

@article{2cf59c21edf643d784535bc007cbaa0e,
title = "Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus",
abstract = "BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group.METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance.RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.",
keywords = "COVID-19, COVID-19 Testing, Consensus, Hematologic Neoplasms/epidemiology, Humans, Pandemics",
author = "C Buske and M Dreyling and A Alvarez-Larr{\'a}n and J Apperley and L Arcaini and C Besson and L Bullinger and P Corradini and {Giovanni Della Porta}, M and M Dimopoulos and S D'Sa and Eich, {H T} and R Fo{\`a} and P Ghia and {da Silva}, {M G} and J Gribben and R Hajek and C Harrison and M Heuser and B Kiesewetter and Kiladjian, {J J} and N Kr{\"o}ger and P Moreau and Passweg, {J R} and F Peyvandi and D Rea and J-M Ribera and T Robak and San-Miguel, {J F} and V Santini and G Sanz and P Sonneveld and {von Lilienfeld-Toal}, M and C Wendtner and G Pentheroudakis and F Passamonti",
note = "Copyright {\textcopyright} 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.",
year = "2022",
month = apr,
doi = "10.1016/j.esmoop.2022.100403",
language = "English",
volume = "7",
journal = "ESMO OPEN",
issn = "2059-7029",
publisher = "BMJ PUBLISHING GROUP",
number = "2",

}

RIS

TY - JOUR

T1 - Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

AU - Buske, C

AU - Dreyling, M

AU - Alvarez-Larrán, A

AU - Apperley, J

AU - Arcaini, L

AU - Besson, C

AU - Bullinger, L

AU - Corradini, P

AU - Giovanni Della Porta, M

AU - Dimopoulos, M

AU - D'Sa, S

AU - Eich, H T

AU - Foà, R

AU - Ghia, P

AU - da Silva, M G

AU - Gribben, J

AU - Hajek, R

AU - Harrison, C

AU - Heuser, M

AU - Kiesewetter, B

AU - Kiladjian, J J

AU - Kröger, N

AU - Moreau, P

AU - Passweg, J R

AU - Peyvandi, F

AU - Rea, D

AU - Ribera, J-M

AU - Robak, T

AU - San-Miguel, J F

AU - Santini, V

AU - Sanz, G

AU - Sonneveld, P

AU - von Lilienfeld-Toal, M

AU - Wendtner, C

AU - Pentheroudakis, G

AU - Passamonti, F

N1 - Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

PY - 2022/4

Y1 - 2022/4

N2 - BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group.METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance.RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.

AB - BACKGROUND: The COVID-19 pandemic has created enormous challenges for the clinical management of patients with hematological malignancies (HMs), raising questions about the optimal care of this patient group.METHODS: This consensus manuscript aims at discussing clinical evidence and providing expert advice on statements related to the management of HMs in the COVID-19 pandemic. For this purpose, an international consortium was established including a steering committee, which prepared six working packages addressing significant clinical questions from the COVID-19 diagnosis, treatment, and mitigation strategies to specific HMs management in the pandemic. During a virtual consensus meeting, including global experts and lead by the European Society for Medical Oncology and the European Hematology Association, statements were discussed and voted upon. When a consensus could not be reached, the panel revised statements to develop consensual clinical guidance.RESULTS AND CONCLUSION: The expert panel agreed on 33 statements, reflecting a consensus, which will guide clinical decision making for patients with hematological neoplasms during the COVID-19 pandemic.

KW - COVID-19

KW - COVID-19 Testing

KW - Consensus

KW - Hematologic Neoplasms/epidemiology

KW - Humans

KW - Pandemics

U2 - 10.1016/j.esmoop.2022.100403

DO - 10.1016/j.esmoop.2022.100403

M3 - SCORING: Journal article

C2 - 35272130

VL - 7

JO - ESMO OPEN

JF - ESMO OPEN

SN - 2059-7029

IS - 2

M1 - 100403

ER -